Detalhe da pesquisa
1.
Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients.
Am J Transplant
; 23(3): 423-428, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906295
2.
Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients.
medRxiv
; 2022 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665017